Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of MEK1/2 inhibitors on cisplatin-induced acute kidney injury (AKI) and cancer growth in mice
Carolyn N. Brown, Daniel Atwood, Deepak Pokhrel, et al.
Cellular Signalling (2020) Vol. 71, pp. 109605-109605
Open Access | Times Cited: 9

Showing 9 citing articles:

Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin
Lauren Thompson, Stacey M. Tuey, Pamela González, et al.
AAPS Open (2025) Vol. 11, Iss. 1
Open Access
Limonin, a natural ERK2 agonist, protects against ischemic acute kidney injury
Xianke Zhou, Yadie Xiang, Dier Li, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 9, pp. 2860-2878
Open Access | Times Cited: 9
Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury
Lauren Thompson, Melanie S. Joy
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 3, pp. 399-414
Closed Access | Times Cited: 3
No safe renal warm ischemia time—The molecular network characteristics and pathological features of mild to severe ischemia reperfusion kidney injury
Yalei Chen, Huai-Kang Li, Lei Wang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 13
RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
Lisa Hunihan, Dejian Zhao, Heather Lazowski, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 14, pp. 3091-3103
Open Access | Times Cited: 12
Evaluation of Cisplatin-Induced Acute Kidney Injury in Patients Co-Prescribed Serotonin Receptor Antagonists: A Retrospective Analysis
Victoria Gutgarts, Supriya Gerardine, Roman Shingarev, et al.
Kidney360 (2024) Vol. 5, Iss. 8, pp. 1094-1100
Open Access | Times Cited: 2
Elevated Stratifin promotes cisplatin-based chemotherapy failure and poor prognosis in non-small cell lung cancer
Yu‐Shui Ma, Likun Hou, Shihua Yao, et al.
Molecular Therapy — Oncolytics (2021) Vol. 22, pp. 326-335
Open Access | Times Cited: 8
Efficacy of Trametinib in Alleviating Cisplatin-Induced Acute Kidney Injury: Inhibition of Inflammation, Oxidative Stress, and Tubular Cell Death in a Mouse Model
Joung Eun Lee, Jung‐Yeon Kim, Jaechan Leem
Molecules (2024) Vol. 29, Iss. 12, pp. 2881-2881
Open Access
miR155 Enhances Autophagy by Reducing MBD5 and METTL3 in Human Liver Cancer Stem Cells
Yanan Lu, Ying‐Jie Chen, Xiaoru Xin, et al.
Research Square (Research Square) (2020)
Open Access
Page 1

Scroll to top